Suchergebnisse - "Lopinavir-Ritonavir"

PubPharm (100)

1

A Comparative Study of Antiretroviral (Lopinavir/Ritonavir) and Remdesivir Used in the Pandemic in Iraq on the Clinical Outcome in Patients with SARS-CoV-2

enthalten in: Archives of Razi Institute | 2023

von Alabdalaali, M. | Hadi, A.

2

Pharmacological treatment of COVID-19 : an opinion paper

enthalten in: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia | 2022

von García-Lledó, A. | Gómez-Pavón, J. | González Del Castillo, J. | +12

3

Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2 : A multicenter prospective study

enthalten in: Medicina intensiva | 2022

von Estella, �. | Garcia Garmendia, J. | de la Fuente, C. | +39

4

Characteristics and outcomes of patients with COVID-19 and liver injury : a retrospective analysis and a multicenter experience

enthalten in: Romanian journal of internal medicine = Revue roumaine de medecine interne | 2022

von Voiosu, A. | Roman, A. | Pop, R. | +6

5

What have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group

enthalten in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2022

von Tiseo, G. | Yahav, D. | Paul, M. | +5

6

Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19-Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)

enthalten in: Frontiers in pharmacology | 2022

von Karolyi, M. | Pawelka, E. | Omid, S. | +18

7

Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19—Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)

in: Frontiers in Pharmacology | 2022

von M. Karolyi | E. Pawelka | S. Omid | +19

8

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Ader, F. | Peiffer-Smadja, N. | Poissy, J. | +56

CommentIn: Clin Microbiol Infect. 2021 Dec;27(12):1716-1717. - PMID 34508887

9

A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State : study protocol for a randomized controlled trial

enthalten in: Trials | 2021

von Abayomi, A. | Osibogun, A. | Ezechi, O. | +8

10

A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial

enthalten in: Trials | 2021

von Abayomi, A. | Osibogun, A. | Ezechi, O. | +8

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]